Gleevec's Rapid Rise To Blockbuster Status

In the 25 years since FDA implemented the landmark Orphan Drug Act, providing incentives to drug makers to develop drugs for rare diseases, the area of drug development has largely been left to nimble biotechs and specialty pharmas